Sydnexis: Pearls from a pediatric ophthalmologist entrepreneur a decade in
May 20 2024
Length: 27 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to Cart failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Please try again

Unfollow podcast failed

Please try again

Sydnexis: Pearls from a pediatric ophthalmologist entrepreneur a decade in

Listen for free

View show details

Summary
Gregory Ostrow, MD, joins Jennifer Galvin, MD, to discuss his entrepreneurism in pediatric ophthalmology and the starting of Sydnexis, a clinical-stage biopharmaceutical company he founded. He describes the journey to discovering a way to neutralize and stabilize compounded atropine eye drops to effectively treat myopia in pediatric patients. He also shares information from the STAR study, a phase 3 clinical trial evaluating the company’s patented formulation of low-dose atropine for myopia control.

Show more Show less

Show more Show less

What listeners say about Sydnexis: Pearls from a pediatric ophthalmologist entrepreneur a decade in

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon